Dave Ricks, CEO of Eli Lilly | The All-In Interview
Oct 12, 2024•1 hr 5 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
(2:06) The obesity problem: a global chronic health epidemic (13:07) The history of discovering GLP-1s (20:38) Impact of GLP-1s on different human functions (27:09) Understanding the commercial aspect of drug discovery, pricing for GLP-1 drugs (33:11) Responding to criticism and research of GLP-1 dependency (40:04) Stock performance, dealing with political pressure related to successful drugs (47:19) Eli Lilly's portfolio of drugs outside of GLP-1s, what science Dave is excited about (56:09) Scaling and impacting culture at a 100+ year-old company
For the best experience, listen in Metacast app for iOS or Android